The present disclosure provides antibodies which bind to an epitope in the extracellular domain of human CC chemokine receptor 4 (CCR4) and which are capable of inhibiting the binding of macrophage - derived chemokine (MDC) and/or thymus and activation regulated chemokine (TARC) to CCR4. Also provided are